EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

A 10‐year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases?

Virginie Barraud-Lange iD, Nicolas Boissel, Anne-Sophie Gille, Camille Jean, Leslie Sitbon, Benoit Schubert iD, Karima Yakouben, Mony Fahd, Matthieu Peycelon, Annabel Paye-Jaouen, Céline Chalas iD, Alexis Vanhaesebrouck and 20 more

Andrology · 2024

DOI: 10.1111/andr.13493 ↗

At a glance

Journal article in Andrology, 2024. Written by Virginie Barraud-Lange and 31 co-authors. Institution: Université Paris Cité, Paris, France. Major MEDLINE topics: Fertility Preservation, Neoplasms. Cited 14 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

A growing number of centers worldwide are preserving testicular tissue (TT) of young boys at risk of fertility loss to preserve their fertility. Data in this regard are scarce and experience sharing is essential to the optimization of the process.

Objectives

This report of our 10‐year activity of pediatric fertility preservation (FP) has the objective to (1) improve knowledge regarding the feasibility, acceptability, safety, and potential usefulness of the procedure; (2) analyze the impact of chemotherapy on spermatogonia in the cryopreserved TT. Materials and methods For this retrospective study of data prospectively recorded, we included all boys under 18 years of age referred to the FP consultation of our academic network between October 2009 and December 2019. Characteristics of patients and cryopreservation of testicular tissue (CTT) were extracted from the clinical database. Univariate and multivariate analyses were used to assess factors associated with the risk of absence of spermatogonia in the TT.

Results

Three hundred and sixty‐nine patients (7.2 years; 0.5–17.0) were referred to the FP consultation for malignant (70%) or non‐malignant (30%) disease, of whom 88% were candidates for CTT, after a previous chemotherapy exposure (78%). The rate of recorded immediate adverse events was 3.5%, with painful episodes dominating. Spermatogonia were detected in the majority of TTs: 91.1% of those exposed to chemotherapy and 92.3% of those not exposed ( p = 0.962). In multivariate analysis, the risk of absence of spermatogonia was almost three‐fold higher in boys > 10 years of age ([OR] 2.74, 95% CI 1.09–7.26, p = 0.035) and four‐fold higher in boys exposed to alkylating agents prior to CTT ([OR] 4.09, 95% CI 1.32–17.94, p = 0.028). Discussion/conclusion This large series of pediatric FP shows that this procedure is well accepted, feasible, and safe in the short term, strengthening its place in the clinical care pathway of young patients requiring a highly gonadotoxic treatment. Our results demonstrate that CTT post‐chemotherapy does not impair the chance to preserve spermatogonia in the TT except when the treatment includes alkylating agents. More data on post‐CTT follow‐up are still required to ensure the long‐term safety and usefulness of the procedure.

Subjects

MeSH terms (MEDLINE)

Fertility PreservationNeoplasmsMaleHumansChildAdolescentTestisRetrospective StudiesCryopreservationAlkylating Agents

Author keywords

alkylating agentboyschemotherapycryopreservationfertility preservationpediatric oncologyprepubertaltesticular tissue

Substances

Alkylating Agents

Authors and institutions

  • Université Paris Cité, Paris, France.
  • Department of Reproductive Biology CECOS, AP-HP. Center-Université Paris Cite. Cochin Hospital, Paris, France.
  • Department of Hematology, Adolescents and Young Adults Unit, AP-HP. North-Université Paris Cité. Saint-Louis Hospital, Paris, France.
  • Biomega-Bioclinic, Department Intercommunal Hospital of Créteil, Assisted Reproductive Biology, Créteil, France.
  • Eurofins Biomnis Laboratory, Institut Rhonalpin IVF Center, Clinique du Val d'Ouest, Ecully, France.
  • Department of Pediatric Immunology and Hematology, APHP. North-Université Paris Cité. Robert Debré Hospital, Paris, France.

ORCID profiles: Virginie Barraud-Lange, Benoit Schubert, Céline Chalas

Cite

APA

Barraud-Lange, V., Boissel, N., Gille, A. S., Jean, C., Sitbon, L., Schubert, B., Yakouben, K., Fahd, M., Peycelon, M., Paye-Jaouen, A., Chalas, C., Vanhaesebrouck, A., Doz, F., Surun, A., Lemelle, L., Sarnacki, S., Neven, B., Philippe-Chomette, P., Dufour, C., …, & Poirot, C. (2024). A 10‐year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases?. Andrology. https://doi.org/10.1111/andr.13493

Vancouver

Barraud-Lange V, Boissel N, Gille AS, Jean C, Sitbon L, Schubert B, et al. A 10‐year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases?. Andrology. 2024. doi:10.1111/andr.13493

BibTeX
@article{BarraudLange2024,
  author = {Barraud-Lange, Virginie and Boissel, Nicolas and Gille, Anne-Sophie and Jean, Camille and Sitbon, Leslie and Schubert, Benoit and Yakouben, Karima and Fahd, Mony and Peycelon, Matthieu and Paye-Jaouen, Annabel and Chalas, Céline and Vanhaesebrouck, Alexis and Doz, François and Surun, Aurore and Lemelle, Lauriane and Sarnacki, Sabine and Neven, Bénédicte and Philippe-Chomette, Pascale and Dufour, Christelle and Rigaud, Charlotte and Leverger, Guy and Tabone, Marie-Dominique and Irtan, Sabine and Pondarée, Corinne and Lezeau, Harry and Lenaour, Gilles and Sibony, Mathilde and Comperat, Eva and Brocheriou, Isabelle and Wolf, Jean Philippe and Dalle, Jean-Hugue and Poirot, Catherine},
  title = {A 10‐year experience in testicular tissue cryopreservation for boys under 18 years of age: What can be learned from 350 cases?},
  journal = {Andrology},
  year = {2024},
  doi = {10.1111/andr.13493}
}
Start for free →